|
The bwi product analysis lab received the device for evaluation on 05-oct-2026.The analysis has begun but is not completed at this time.When the investigational analysis has been completed, a supplemental 3500a report will be submitted.Additional information was received on 05-oct-2026.The hemostatic valve did not dislodge.The brim cap and hub did not become detached from the sheath.Xerostar needle used.If additional information is received regarding this event, a supplemental 3500a report will be submitted to the fda.Manufacturer's reference number:(b)(4).
|